Skyline Medical Inc. (SKLN) Reaches $0.94 52-Week Low; Profile of 4 Analysts Covering Reckitt Benckiser Group plc (RBGLY)

January 7, 2018 - By Vivian Park

Among 8 analysts covering Reckitt Benckiser (OTCMKTS:RBGLY), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Reckitt Benckiser had 9 analyst reports since August 12, 2015 according to SRatingsIntel. HSBC upgraded the stock to “Buy” rating in Thursday, January 7 report. The rating was initiated by Morgan Stanley on Thursday, December 8 with “Equal-Weight”. The stock has “Buy” rating by Berenberg on Wednesday, January 25. The firm earned “Overweight” rating on Thursday, September 3 by JP Morgan. The stock of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has “Neutral” rating given on Wednesday, August 12 by Goldman Sachs. The stock of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) earned “Outperform” rating by RBC Capital Markets on Wednesday, January 25. BNP Paribas downgraded Reckitt Benckiser Group plc (OTCMKTS:RBGLY) on Wednesday, September 7 to “Neutral” rating. Citigroup initiated Reckitt Benckiser Group plc (OTCMKTS:RBGLY) on Thursday, September 1 with “Buy” rating. The stock has “Underperform” rating by RBC Capital Markets on Monday, February 6. See Reckitt Benckiser Group plc (OTCMKTS:RBGLY) latest ratings:

The stock of Skyline Medical Inc. (NASDAQ:SKLN) hit a new 52-week low and has $0.91 target or 3.00% below today’s $0.94 share price. The 8 months bearish chart indicates high risk for the $5.88 million company. The 1-year low was reported on Jan, 7 by Barchart.com. If the $0.91 price target is reached, the company will be worth $176,310 less. The stock decreased 5.52% or $0.0546 during the last trading session, reaching $0.9354. About 2.17 million shares traded or 321.92% up from the average. Skyline Medical Inc. (NASDAQ:SKLN) has declined 52.09% since January 7, 2017 and is downtrending. It has underperformed by 68.79% the S&P500.

The stock increased 1.95% or $0.36 during the last trading session, reaching $18.83. About 954,292 shares traded or 30.20% up from the average. Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has 0.00% since January 7, 2017 and is . It has underperformed by 16.70% the S&P500.

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company has market cap of $63.91 billion. The firm offers treatment products for analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl, and Strepsils brand names. It has a 27.29 P/E ratio. It also offers hygienic products, including surface care and lavatory care products, antiseptic liquids, pest control products, automatic dishwashing products, automatic dishwashing products, and depilatory products under the Cillit Bang, Clearasil, Dettol, Finish, Harpic, Lysol, Mortein, and Veet brand names.

Skyline Medical Inc., a medical device company, makes environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the United States. The company has market cap of $5.88 million. It offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. It currently has negative earnings. The companyÂ’s system replaces the manual process of collecting fluids in canisters, and transporting and dumping in sinks outside of the operating room.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com